About
OmeBio exists because a clinician needed a domestic peptide source he could trust, and couldn't find one.
The problem was consistent. Peptides sourced from overseas labs arrived with incomplete certificates of analysis, inconsistent potency, and no transparency into manufacturing conditions. For a clinician injecting compounds into patients, that uncertainty was unacceptable.
OmeBio was built to solve that problem at the standard practitioners actually need. A cGMP-certified 503B compounding laboratory, located in the United States, producing pharmaceutical-grade peptides and biologics with full documentation at every step.
Unlike compound pharmacies, OmeBio's manufacturing partner functions as a wet-lab research facility. They hold contracts with government organizations, hospitals, and pharmacies for production of peptides, biologics, blood products, vitamins, and flavonoids. This is not a white-label operation or a marketplace. It is a dedicated facility with the infrastructure, licensing, and institutional relationships to produce at the standard clinicians require.
Every compound is made here, tested here, and documented here.
Values
Every decision filters through one question: does this serve the clinician treating the patient? Product development, documentation, packaging, support. All of it is designed for the people doing the work.
Every compound ships with a complete certificate of analysis. Third-party testing. Full potency, purity, and sterility documentation. We give practitioners the data to verify for themselves.
A cGMP-certified 503B compounding laboratory in the United States. No offshore sourcing, no intermediary labs. From raw material to finished vial, under one roof with full traceability.
Compounds without outcome data are just products. We encourage every practitioner to track patient outcomes and provide free software to make that possible.
Access
OmeBio compounds are available exclusively to licensed clinicians and researchers.
Apply for access